|
|
|
|
,
a privately-held, early-stage biomedical company dedicated to advancing
combination product therapies in the cardiovascular, orthopedic, and
drug-delivery areas.
Our
Supercritical Fluid Technology consists of patented processes and methods
for surface modifications of medical devices with specific focus on improvements
to current polymer based drug-eluting technologies. Included in our technology
platform are exclusively licensed patents from Battelle. The patented
technology was developed at
Pacific Northwest National Laboratory, a U.S. Department of Energy
laboratory, managed by Battelle.
Our development team has significant expertise in supercritical fluid technology
and has developed semiconductor and industrial applications.
|
|
|
|
|
Watch Video
